June 12, 2025
Women admitted to ICU for interstitial lung disease (ILD) had shorter hospital stays and a lower risk for death than men, based on a new analysis […]
June 10, 2025
TOPLINE: Long-acting muscarinic antagonists (LAMAs), as add-on therapy to inhaled corticosteroids, improved peak forced expiratory volume in 1 second (FEV1) and reduced exacerbations in children younger […]
June 9, 2025
Potential climate change scenarios could nearly double the global incidence of obstructive sleep apnea (OSA), based on estimates from a new study presented at American Thoracic […]
June 4, 2025
TOPLINE: Individuals with chronic obstructive pulmonary disease (COPD) were vulnerable to even small increases in fine particulate matter < 2.5 μm in diameter (PM2.5), with significantly […]
June 3, 2025
TOPLINE: Among older adults in the western United States, exposure to high concentrations of smoke-related fine particulate matter (PM2.5) was associated with increased rates of hospitalizations […]
June 2, 2025
The addition of tezepelumab to standard treatment allowed half the adults with severe asthma to discontinue their use of oral corticosteroids (OCS) after 1 year, according […]
May 28, 2025
SAN FRANCISCO — A molecular variant of an older, hard-to-tolerate antifibrotic agent showed promise for reducing decline in forced vital capacity (FVC) over 26 weeks among […]
May 27, 2025
Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the […]
May 22, 2025
Approximately 20% of patients who undergo bronchoscopic lung volume reduction (BLVR) lose the effects of the treatment within 2 years, according to data presented at the […]